Effect of Probiotics on Gut-Liver Axis of Alcoholic Liver Disease
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
Background/Aims:
The investigators explored the therapeutic effects of probiotics in patients with AH.
Methods:
Between September 2010 and April 2012, the investigators conducted a 7-day,
double-controlled, randomized, prospective clinical trial comparing the efficacy of
probiotics in improving liver enzymes, LPS, pro-inflammatory cytokines. AH was defined as an
aspartate aminotransferase (AST)/alanine aminotransferase (ALT) > 2 and elevated AST (ALT)
level with an alcohol consumption history within 48 hours. Patients were randomized to
receive 7 days of probiotics (1500 mg/day) or placebo. The levels of liver enzymes, modified
Discriminant Function (mDF), LPS, and pro-inflammatory cytokines were checked at baseline and
again after therapy.